UK markets open in 7 hours 35 minutes

Helix BioMedix, Inc. (HXBM)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
23.270.00 (0.00%)
At close: 10:31AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 7.13M
Enterprise value 7.13M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.41
Price/book (mrq)4.32
Enterprise value/revenue 3.45
Enterprise value/EBITDA -3.06

Trading information

Stock price history

Beta (5Y monthly) 0.35
52-week change 3-0.13%
S&P500 52-week change 324.19%
52-week high 323.36
52-week low 323.00
50-day moving average 323.27
200-day moving average 323.24

Share statistics

Avg vol (3-month) 36
Avg vol (10-day) 3N/A
Shares outstanding 5165.72k
Implied shares outstanding 6249.25k
Float 8N/A
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:300
Last split date 303 Jan 2013

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2011
Most-recent quarter (mrq)30 Sept 2012

Profitability

Profit margin -125.06%
Operating margin (ttm)-159.50%

Management effectiveness

Return on assets (ttm)-59.00%
Return on equity (ttm)-122.53%

Income statement

Revenue (ttm)2.07M
Revenue per share (ttm)12.47
Quarterly revenue growth (yoy)18.80%
Gross profit (ttm)N/A
EBITDA -2.33M
Net income avi to common (ttm)-2.58M
Diluted EPS (ttm)-11.64
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)216.53k
Total cash per share (mrq)1.31
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)2.33
Book value per share (mrq)6.94

Cash flow statement

Operating cash flow (ttm)-1.82M
Levered free cash flow (ttm)-1.08M